Dashboard
Manage Tickers

FBIO Fortress Biotech, Inc.

Nasdaq fortressbiotech.com


$ 2.75 $ 0.03 (1.11 %)    

Tuesday, 14-Oct-2025 13:11:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 602.08 $ 6.87 (1.15 %)
DIA $ 464.40 $ 7.39 (1.62 %)
SPY $ 665.11 $ 7.83 (1.19 %)
TLT $ 90.63 $ 0.00 (0 %)
GLD $ 381.65 $ 3.30 (0.87 %)
$ 2.8
$ 2.70
$ 2.72 x 458
$ 2.75 x 318
$ 2.60 - $ 2.76
$ 1.33 - $ 4.20
416,925
na
92.91M
$ 1.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 08-14-2023 06-30-2023 10-Q
9 05-15-2023 03-31-2023 10-Q
10 03-31-2023 12-31-2022 10-K
11 11-14-2022 09-30-2022 10-Q
12 08-11-2022 06-30-2022 10-Q
13 05-12-2022 03-31-2022 10-Q
14 03-28-2022 12-31-2021 10-K
15 11-15-2021 09-30-2021 10-Q
16 08-16-2021 06-30-2021 10-Q
17 05-17-2021 03-31-2021 10-Q
18 03-31-2021 12-31-2020 10-K
19 11-09-2020 09-30-2020 10-Q
20 08-10-2020 06-30-2020 10-Q
21 05-11-2020 03-31-2020 10-Q
22 03-16-2020 12-31-2019 10-K
23 11-12-2019 09-30-2019 10-Q
24 08-09-2019 06-30-2019 10-Q
25 05-10-2019 03-31-2019 10-Q
26 03-18-2019 12-31-2018 10-K
27 11-09-2018 09-30-2018 10-Q
28 08-09-2018 06-30-2018 10-Q
29 05-10-2018 03-31-2018 10-Q
30 03-16-2018 12-31-2017 10-K
31 11-09-2017 09-30-2017 10-Q
32 08-09-2017 06-30-2017 10-Q
33 05-10-2017 03-31-2017 10-Q
34 03-16-2017 12-31-2016 10-K
35 11-09-2016 09-30-2016 10-Q
36 08-09-2016 06-30-2016 10-Q
37 05-10-2016 03-31-2016 10-Q
38 03-15-2016 12-31-2015 10-K
39 11-09-2015 09-30-2015 10-Q
40 08-10-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 17:06:01

cal-maine-foods-posts-downbeat-earnings-joins-enanta-pharmaceuticals-aar-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Cal-Maine Foods Posts Downbeat Earnings, J...
10/01/2025 12:16:06

fortress-biotech-and-cyprium-therapeutics-announce-fda-issues-crl-relating-to-nda-for-cutx-101-intended-to-treat-menkes-disease-in-pediatric-patients
Fortress Biotech And Cyprium Therapeutics ...
10/01/2025 12:15:20

Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ("C...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

fortress-biotech-announces-fda-issued-complete-response-letter-related-to-nda-for-cutx-101
Fortress Biotech Announces FDA Issued Comp...
10/01/2025 12:02:17

why-ryvyl-shares-are-trading-higher-by-97-here-are-20-stocks-moving-premarket
Why Ryvyl Shares Are Trading Higher By 97%...
10/01/2025 09:45:27

why-docusign-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Docusign Shares Are Trading Higher By ...
09/05/2025 09:20:59

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/29/2025 21:06:12

hc-wainwright--co-maintains-buy-on-fortress-biotech-lowers-price-target-to-17
HC Wainwright & Co. Maintains Buy on Fortr...
08/21/2025 11:14:25

HC Wainwright & Co. analyst Joseph Pantginis maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and lowers the price ta...

correction-fortress-biotech-q2-adj-eps-046-misses-036-estimate-sales-16413m-beat-14534m-estimate
CORRECTION: Fortress Biotech Q2 Adj. EPS $...
08/14/2025 22:21:05

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(...

fortress-biotech-reveals-astrazenecas-anselamimab-trial-did-not-achieve-statistical-significance
Fortress Biotech Reveals AstraZeneca's Ans...
07/16/2025 21:31:04

-SEC Filing

fortress-biotech-q1-eps-048-beats-049-estimate-sales-1314m-beat-1162m-estimate
Fortress Biotech Q1 EPS $(0.48) Beats $(0....
05/15/2025 20:31:39

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0....

partex-and-fortress-biotech-announces-a-strategic-collaboration-aimed-at-identifying-and-evaluating-biopharmaceutical-compounds-using-ai-for-potential-acquisition-or-licensing-by-fortress
Partex And Fortress Biotech Announces A St...
03/17/2025 12:59:34

Partex NV and Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"), an innovative biopharmaceutical company, today announc...

roth-mkm-reiterates-buy-on-fortress-biotech-raises-price-target-to-16
Roth MKM Reiterates Buy on Fortress Biotec...
03/11/2025 14:49:54

Roth MKM analyst Jason Wittes reiterates Fortress Biotech (NASDAQ:FBIO) with a Buy and raises the price target from $15 to $16.

india-based-sun-pharma-to-buy-us-cancer-firm-checkpoint-therapeutics-details
India-Based Sun Pharma To Buy US Cancer Fi...
03/10/2025 15:08:51

Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 b...

Core News & Articles
Mustang Bio Exits Lease Of Manufacturing F...
02/27/2025 21:46:51

fortress-biotech-doses-first-patient-in-phase-2-clinical-trial-of-triplex-vaccination-in-stem-cell-donors
Fortress Biotech Doses First Patient In Ph...
01/27/2025 13:32:36

Study is the first randomized, controlled trial examining a vaccine's effectiveness in controlling CMV in recipients of HSC...

correction-fortress-biotechs-cyprium-therapeutics-announces-fda-extended-nda-target-date-for-cutx-101-to-september-30-2025-sentynl-responsible-for-development-and-commercialization-cyprium-retains-priority-review-voucher-rights-eligible-for-up-to-129m-royalties-and-milestones
CORRECTION: Fortress Biotech's Cyprium The...
01/16/2025 21:25:46

r

fortress-biotech-cyprium-therapeutics-announce-fda-acceptance-priority-review-of-nda-for-cutx-101-for-treatment-of-menkes-disease
Fortress Biotech, Cyprium Therapeutics Ann...
01/06/2025 13:03:04

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025Cyprium is eligible to receive royaltie...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION